J.G. Baril

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Antonella Castagna, Franco Maggiolo, Giovanni Penco et al. · The Journal of Infectious Diseases · 2014 · 329 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Long-Term Efficacy and Safety of Fosamprenavir plus Ritonavir Versus Lopinavir/Ritonavir in Combination with Abacavir/Lamivudine over 144 Weeks

Federico Pulido, Vicente Estrada, J.G. Baril et al. · HIV Clinical Trials · 2009 · 32 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Predictors of chlamydial infection and gonorrhea among patients seen by private practitioners.

Jean Vincelette, J.G. Baril, R. W. Allard · PubMed · 1991 · 17 citations

Veterinary Medicine, Infectious Diseases, Obstetrics +17

Design and Implementation of a Randomized Crossover Study of Valproic Acid and Antiretroviral Therapy to Reduce the HIV Reservoir

Jean‐Pierre Routy, Jonathan B. Angel, Johanna N. Spaans et al. · HIV Clinical Trials · 2012 · 12 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17